Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

IFN-mediated NAD depletion by upregulation of PARP9/10/14 sensitizes PDAC cells to NAMPT inhibitors

March 15, 2021

Galapagos presents TYK2 inhibitors

March 15, 2021

Inflazome synthesizes new NLRP3 inflammasome inhibitors

March 15, 2021

Hunan Warrant Pharmaceuticals patents Bcr-Abl1 and/or BTK inhibitors

March 15, 2021

Targeting membrane protein starves pancreatic tumors

March 15, 2021

Genfleet Therapeutics presents GTPase KRAS mutant inhibitors

March 12, 2021

BeiGene discloses MAP4K1 inhibitors

March 12, 2021

Enrollment opens in phase III trial of [177Lu]PNT-2002 for metastatic CRPC

March 12, 2021

FDA approves Fotivda for relapsed or refractory advanced RCC

March 11, 2021

Dosing initiates in first-in-human study of IMP-7068 in advanced solid tumors

March 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...